Share the post "Procter & Gamble Hygiene & Health Care Ltd.’s Quarterly Result and Earnings Report for Q4(Mar 2024) : Sales increased by (13.48) % in YoY and decreased by 11.58 % in QoQ"
Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 13.48 % in the past year, decrease in net sales/revenue by -11.58 %.
- Income over the Year and quarter: There has been decline in other income over the past year which is -5.89 %, Marginal decrease of -12.77% in other income during this quarter.
- Profit over the Year and quarter: Challenges in sustaining profitability for Procter & Gamble Hygiene & Health Care Ltd.. Profit dropped by -6.45 % Year to Year, Procter & Gamble Hygiene & Health Care Ltd.’s profitability dropped by -32.56 % Quarter to Quarter.
- EPS over the Year and quarter: EPS declined by -6.45 % Year to Year. EPS decreased by -32.55 % in previous quarter. Analysis needed for shareholder value.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 883.09 Cr | Rs. 1133.43 Cr | Rs. 1002.17 Cr | -11.58 % | + 13.48 % |
| Expenses | Rs. 733.82 Cr | Rs. 823.69 Cr | Rs. 744.86 Cr | -9.57 % | + 1.5 % |
| Operating Profit | Rs. 149.27 Cr | Rs. 309.74 Cr | Rs. 257.31 Cr | -16.93 % | + 72.38 % |
| OPM % | 16.9 % | 27.33 % | 25.68 % | -1.65 % | + 8.78 % |
| Other Income | Rs. 14.44 Cr | Rs. 15.58 Cr | Rs. 13.59 Cr | -12.77 % | -5.89 % |
| Interest | Rs. 3.57 Cr | Rs. 2.55 Cr | Rs. 22.42 Cr | + 779.22 % | + 528.01 % |
| Depreciation | Rs. 14.58 Cr | Rs. 14.26 Cr | Rs. 14.54 Cr | + 1.96 % | -0.27 % |
| Profit before tax | Rs. 145.56 Cr | Rs. 308.51 Cr | Rs. 233.94 Cr | -24.17 % | + 60.72 % |
| Tax % | 13.37 % | 25.8 % | 34.01 % | + 8.21 % | + 20.64 % |
| Net Profit | Rs. 165.02 Cr | Rs. 228.9 Cr | Rs. 154.37 Cr | -32.56 % | -6.45 % |
| EPS in Rs | Rs. 50.84 | Rs. 70.51 | Rs. 47.56 | -32.55 % | -6.45 % |
Today, we’re looking at Procter & Gamble Hygiene & Health Care Ltd.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 13.48 %. However, it did see a marginal slip of -11.58 % from the previous quarter. Expenses decreased slightly by -9.57 % quarter-on-quarter, aligning with the annual rise of 1.5 %. Operating profit, while up 72.38 % compared to last year, faced a quarter-on-quarter dip of -16.93 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 8.78 %, but a shrinkage of -1.65 % sequentially. Other income fell by -12.77 % compared to the last quarter, despite an annual decline of -5.89 %. Interest expenses surged remarkably by 779.22 % from the previous quarter, yet the year-over-year increase remains at a moderate 528.01 %. Depreciation costs climbed by 1.96 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -0.27 %. Profit before tax grew annually by 60.72 % but saw a reduction from the preceding quarter by -24.17 %.
Tax expenses as a percentage of profits increased slightly by 20.64 % compared to last year, with a more notable quarter-on-quarter increase of 8.21 %. Net profit fell by -6.45 % year-on-year but witnessed a -32.56 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -6.45 % but a quarterly fall of -32.55 %. In summary, Procter & Gamble Hygiene & Health Care Ltd.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 883.09 Cr | Rs. 1133.43 Cr | Rs. 1002.17 Cr | -11.58 % | + 13.48 % |
| Expenses | Rs. 733.82 Cr | Rs. 823.69 Cr | Rs. 744.86 Cr | -9.57 % | + 1.5 % |
| Operating Profit | Rs. 149.27 Cr | Rs. 309.74 Cr | Rs. 257.31 Cr | -16.93 % | + 72.38 % |
| Net Profit | Rs. 165.02 Cr | Rs. 228.9 Cr | Rs. 154.37 Cr | -32.56 % | -6.45 % |
| EPS in Rs | Rs. 50.84 | Rs. 70.51 | Rs. 47.56 | -32.55 % | -6.45 % |
In reviewing Procter & Gamble Hygiene & Health Care Ltd.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 13.48 % year-on-year growth, although there was a slight dip of -11.58 % from the previous quarter. Expenses rose by 1.5 % compared to the previous year, with a decrease of -9.57 % quarter-on-quarter. Operating Profit surged by 72.38 % annually, and saw a -16.93 % decrease from the last quarter.
Net Profit showed yearly decrease of -6.45 %, and experienced a -32.56 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -6.45 % annually, however dipped by -32.55 % compared to the last quarter. In essence, while Procter & Gamble Hygiene & Health Care Ltd. exhibits strong annual growth indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
